Chronic DVT ‐ antiplatelet agents plus BMP vs BMP plus placebo
Mortality ‐ intermediate and long term · people requiring treatment for chronic DVT
Chronic DVT ‐ antiplatelet agents plus BMP showed no clear difference in mortality ‐ intermediate and long term compared with BMP plus placebo (moderate certainty).
1 finding from 1 review
- Antiplatelet agents for the treatment of deep venous thrombosis 2022 · Cochrane Headline outcomes onlyRR 0.48 [0.21, 1.06]3 studies · 649 participantsModerate